Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

387 questions in 55 reviews · Common Mental Disorders

current versions
No studies 387 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Intervention NR
Prevalence of fear of childbirth (short term: up to 3 months postpartum) · Women of any age who had given birth within one month of the intervention being offered
Debriefing interventions for the prevention of psychological trauma in women following childbirth (2015) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Prevalence of general psychological morbidity (short term: up to 3 months postpartum) · Women of any age who had given birth within one month of the intervention being offered
Debriefing interventions for the prevention of psychological trauma in women following childbirth (2015) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Health service utilization (short term: up to 3 months postpartum) · Women of any age who had given birth within one month of the intervention being offered
Debriefing interventions for the prevention of psychological trauma in women following childbirth (2015) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Attrition from treatment (short term: up to 3 months postpartum) · Women of any age who had given birth within one month of the intervention being offered
Debriefing interventions for the prevention of psychological trauma in women following childbirth (2015) · Cochrane
no estimate extractedNRNo studies
DCS and cognitive and behavioural therapies vs placebo and cognitive and behavioural therapies
Quality of life · Children and adolescents with anxiety disorders
Augmentation of cognitive and behavioural therapies (CBT) with d‐cycloserine for anxiety and related disorders (2015) · Cochrane
no estimate extractedNRNo studies
Morita therapy plus pharmacological therapy vs pharmacological therapy alone
Quality of life measures ‐ endpoint data or change data · people with anxiety disorders
Morita therapy for anxiety disorders in adults (2015) · Cochrane
no estimate extractedNRNo studies
Morita therapy plus pharmacological therapy vs pharmacological therapy alone
Measures of functioning ‐ endpoint data or change data · people with anxiety disorders
Morita therapy for anxiety disorders in adults (2015) · Cochrane
no estimate extractedNRNo studies
Morita therapy vs pharmacological therapy
Acceptability ‐ drop‐outs for any reason · people with social phobia
Morita therapy for anxiety disorders in adults (2015) · Cochrane
no estimate extractedNRNo studies
Morita therapy vs pharmacological therapy
Measures of obsession and compulsion endpoint data or change data · people with social phobia
Morita therapy for anxiety disorders in adults (2015) · Cochrane
no estimate extractedNRNo studies
Morita therapy vs pharmacological therapy
Quality of life measures endpoint data or change data · people with social phobia
Morita therapy for anxiety disorders in adults (2015) · Cochrane
no estimate extractedNRNo studies
Morita therapy vs pharmacological therapy
Measures of functioning endpoint data or change data · people with social phobia
Morita therapy for anxiety disorders in adults (2015) · Cochrane
no estimate extractedNRNo studies
Morita therapy plus pharmacological therapy vs pharmacological therapy alone
Global state responders · people with anxiety disorders
Morita therapy for anxiety disorders in adults (2015) · Cochrane
no estimate extractedNRNo studies
Comparison 2: interventions for patients with multiple episodes of SH or emerging personality problems vs treatment
Mentalisation · children and adolescents who engage in SH.
Interventions for self‐harm in children and adolescents (2015) · Cochrane
no estimate extractedNRNo studies
Paroxetine vs citalopram
Failure to remit at endpoint · patients with depression
Paroxetine versus other anti‐depressive agents for depression (2014) · Cochrane
no estimate extractedNRNo studies
rTMS + pharmacotherapy vs sham rTMS + pharmacotherapy
Reduction of panic symptoms: Panic Disorder Severity Scale (PDSS) (high=poor, data skewed) PDSS, Scale from: 0 to 28) · participants with panic disorder
Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults (2014) · Cochrane
no estimate extractedNRNo studies
rTMS + pharmacotherapy vs sham rTMS + pharmacotherapy
Quality of life (such as the SF‐36 Health Survey (Ware 1992) · participants with panic disorder
Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults (2014) · Cochrane
no estimate extractedNRNo studies
rTMS + pharmacotherapy vs sham rTMS + pharmacotherapy
Safety of rTMS: Frequency of rTMS side effects (values are percentages) self‐reported questionnaire · participants with panic disorder
Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults (2014) · Cochrane
no estimate extractedNRNo studies
Psychological intervention vs control
Adverse events · people of any age who have survived any type of torture
Psychological, social and welfare interventions for psychological health and well‐being of torture survivors (2014) · Cochrane
no estimate extractedNRNo studies
Psychological intervention vs control
Improvement in quality of life— · people of any age who have survived any type of torture
Psychological, social and welfare interventions for psychological health and well‐being of torture survivors (2014) · Cochrane
no estimate extractedNRNo studies
Psychological intervention vs control
Improvement in participation · people of any age who have survived any type of torture
Psychological, social and welfare interventions for psychological health and well‐being of torture survivors (2014) · Cochrane
no estimate extractedNRNo studies
Psychological intervention vs control
Improvement in family or social relationships · people of any age who have survived any type of torture
Psychological, social and welfare interventions for psychological health and well‐being of torture survivors (2014) · Cochrane
no estimate extractedNRNo studies
Psychological intervention vs control
Satisfaction with treatment · people of any age who have survived any type of torture
Psychological, social and welfare interventions for psychological health and well‐being of torture survivors (2014) · Cochrane
no estimate extractedNRNo studies
Tricyclic antidepressants vs placebo
Acceptability (all‐cause drop‐outs) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Natural products vs placebo
Functional disability and quality of life (post‐treatment score on self report scales) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Tricyclic antidepressants vs another medication
Functional disability and quality of life · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Tricyclic antidepressants vs placebo
Anxiety (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Antidepressants vs a combination of medications
Adverse effects (drop‐outs due to adverse effects) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Antidepressants vs a combination of medications
Treatment response (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Antidepressants vs a combination of medications
Functional disability and quality of life · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Tricyclic antidepressants vs placebo
Depression (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Tricyclic antidepressants vs placebo
Adverse effects (drop‐outs due to adverse effects) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Tricyclic antidepressants vs placebo
Treatment response (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Tricyclic antidepressants vs placebo
Functional disability and quality of life (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults
Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane
no estimate extractedNRNo studies
Azapirone vs placebo
Rate of 'response' · adults with panic disorder
Azapirones versus placebo for panic disorder in adults (2014) · Cochrane
no estimate extractedNRNo studies
CBT vs no treatment
Outcomes3 · patients with adjustment disorders
Interventions to facilitate return to work in adults with adjustment disorders (2012) · Cochrane
no estimate extractedNRNo studies
Amitriptyline vs placebo
Death due to suicide · adults with major depressive disorder
Amitriptyline versus placebo for major depressive disorder (2012) · Cochrane
no estimate extractedNRNo studies
Amitriptyline vs placebo
Quality of life · adults with major depressive disorder
Amitriptyline versus placebo for major depressive disorder (2012) · Cochrane
no estimate extractedNRNo studies